A collaborative U-M team shows that liver injury is less likely to originate from popular cancer immunotherapy drug, pembrolizumab, than tumor progression.
An enzyme’s newly discovered ability to spur the body to prevent or repair acute liver injury in mice could be harnessed as a therapy or used as a biomarker.<
A recent paper from two U-M hepatologists highlights the liver dangers associated with consuming some herbal and dietary supplements designed to build muscle or lose weight.
Providing physicians with virtual access to specialists can be lifesaving to liver disease patients. A new study finds that it boosts survival rates by 54 percent.
Access to health care for veterans with liver disease is highlighted in a new paper, which links visits to specialists with improved treatment outcomes.